VIDAZA 25 MG / ML
azacitidine
Public price
3.259,00 MAD
Active substance
azacitidine
Laboratory
MAPHAR
What is this medicine?
Azacitidine is a pyrimidine nucleoside analog of cytidine that inhibits DNA/RNA methyltransferases, reducing DNA and RNA methylation to alter gene expression and induce apoptosis in cancer cells.
Verified summary
azacitidine, Poudre pour suspension injectable, 25 MG, Flacon de 30 ML
Common uses
Continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.
Class
Nucleoside metabolic inhibitor
Laboratory
MAPHAR
Hospital price
2.943,00 MAD
Strength
25 MG
Form
Poudre pour suspension injectable
Presentation
Flacon de 30 ML
ATC code
L01BC07
Type
Princeps
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 3.259,00 MAD
Available presentations and strengths
Medicines with the same active substance
AZACITEA
100 MG · BOITE DE 1 FLACON
1,92 MAD
WINDUZA
100 MG · BOITE DE 1 flacon
1,92 MAD
VIDAZA
25 MG / ML · FLACON DE 30 ML
3,26 MAD
AZACITEA 100 MG
100 MG · 1 flacon
1.919,00 MAD
AZACITEA 100 MG
100 MG · Poudre pour injection en flacon
1.919,00 MAD
WINDUZA 100 MG
100 MG · Boite de 1 flacon
1.919,00 MAD
AZALID
25 MG / ML · BOITE D'UN FLACON
Not available in the verified source
AZALID
25 MG / ML · BOITE DE 10 FLACONS
Not available in the verified source